Lilly Drug Chosen for Alzheimer's Prevention Study

Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .
Harvard Medical School

   Advertisement
Carepass Ad Carepass Ad .
Chrome 2001
Chrome 2001
.

Lilly Drug Chosen for Alzheimer's Prevention Study

Seniors' Health
22030
Senior Health
Lilly Drug Chosen for Alzheimer's Prevention Study
Lilly Drug Chosen for Alzheimer's Prevention Study
apdigital_2013_01_18_ap.online.health-medical_DA3SPPRO2_news_ap_org.anpa
(Associated Press) -- Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study aiming to prevent Alzheimer's disease in older people at high risk of developing it.
1471788
InteliHealth
2013-01-18
t
Associated Press
2013-02-17
Associated Press
Lilly Drug Chosen for Alzheimer's Prevention Study
January 18, 2013

(Associated Press) -- Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study aiming to prevent Alzheimer's disease in older people at high risk of developing it.

The drug, called solanezumab (sol-ah-NAYZ-uh-mab), is designed to bind to and help clear the sticky deposits that clog patients' brains.

Earlier studies found it did not help people with moderate to severe Alzheimer's but it showed some promise against milder disease.

Researchers think it might work better if given before symptoms start. The new study will test it in 1,000 people ages 70 and older whose brain scans show plaque buildup but who do not yet have any symptoms of dementia.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

341, 8896, 20774, 21291, 24524,
drug
8896
Last updated January 18, 2013


    Print Printer-friendly format    
   
.
.  
This website is certified by Health On the Net Foundation. Click to verify.
.